Organigram Global (OGI) Cash from Discontinued Operations (2019 - 2026)
Organigram Global (OGI) reported Cash from Discontinued Operations of 4929430477.56 for Q1 2026, up 57.35% year-over-year from 3132744563.72 in Q1 2025, and down 42929083.38% quarter-over-quarter from 11482.7 in Q4 2025.
Organigram Global (OGI) Cash from Discontinued Operations (2019 - 2026) Analysis & Trends
Organigram Global (OGI) has 6 years of Cash from Discontinued Operations data on file, last reported at 4929430477.56 in Q1 2026.
- Cash from Discontinued Operations for Q1 2026 came in at 4929430477.56, up 57.35% year-over-year; the trailing twelve-month figure through Mar 2026 was 16487804708.82 (up 49.64% YoY), and the FY2021 annual result was 9341000000.0, changed N/A from the prior year.
- Cash from Discontinued Operations fell to 4929430477.56 in Q1 2026 per OGI's latest filing, from 11482.7 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 2992.25 in Q4 2024 and troughed at 11558359756.31 in Q1 2025.
- A 3-year average of 4121951177.21 and a median of 2464720980.13 in 2025 frame the typical range for Cash from Discontinued Operations.
- The sharpest annual moves came in 2025 and 2026: Cash from Discontinued Operations slumped 283.75% in 2025, then surged 57.35% in 2026.
- A 3-year view of Cash from Discontinued Operations shows it stood at 2992.25 in 2024, then tumbled by 283.75% to 11482.7 in 2025, then slumped by 42929083.38% to 4929430477.56 in 2026.
- Business Quant data shows OGI's Cash from Discontinued Operations at 4929430477.56 in Q1 2026, 11482.7 in Q4 2025, and 11558359756.31 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Organigram Global | 731.20 Mn | 673.26 Mn | 11.96 Mn | -4.93 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.93 Bn |
| Mar 31, 2026 | -4.93 Bn |
| Dec 31, 2025 | -11,482.70 |
| Dec 31, 2025 | -11,482.70 |
| Mar 31, 2025 | -11.56 Bn |
| Mar 31, 2025 | -11.56 Bn |
| Dec 31, 2024 | -2,992.25 |
| Dec 31, 2024 | -2,992.25 |
| May 31, 2021 | -10.75 Bn |
| May 31, 2021 | -10.75 Bn |
| Feb 28, 2021 | -10.43 Bn |
| Feb 28, 2021 | -10.43 Bn |
| Nov 30, 2020 | 294.00 Mn |
| Nov 30, 2020 | 294.00 Mn |
| May 31, 2020 | 313.00 |
| May 31, 2020 | 313.00 |
| Nov 30, 2019 | -26,868.00 |
| Nov 30, 2019 | -26,868.00 |